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Abstract 
Tuberculosis incidence is low in Switzer land.
We report here on a Swiss-born toddler.
Tuberculosis manifested with a fever of
unknown origin, mimicking an inflammatory
or autoimmune disorder triggering a high dose
of corticosteroid treatment. The disease went
unrecognized for several weeks until develop-
ment of a miliary tuberculosis with advanced
central nervous system involvement. This case
highlights the difficulties encountered in diag-
nosing tuberculosis and in identifying the ori-
gin of this case. It reminds us that this disease
must never be forgotten when facing a child
with persistent fever who must be screened for,
before starting immunosuppressive therapy.
Case Report
This boy was in excellent general condition
until 23 months of age when he started pre-
senting daily bouts of fever without localizing
signs. The fever subsided with no antimicro-
bial therapy after 10 days. The spontaneous
clinical resolution precluded further investiga-
tions despite elevated inflammation parame-
ters (CRP 60 mg/L, ESR 40 mm/h, hemoglobin
109 g/L, leukocyte count 11.8 G/L). The fever
bouts recurred twice in the following three
months. The third recurrence did not resolve
spontaneously. Recurrences came along with
some fatigability and a history of transient
limp while rising up in the morning suggest-
ing arthritis, as well as a transient ill-defined
skin rash concomitant with a fever peak.
Investigations performed at this time (chest X-
ray, imaging study of the hip and abdomen,
serology screening) turned out normal except
the chest x-ray showing a diffuse micro-nodu-
lar infiltrate consistent with a viral bronchial
infection (Figure 1). No other significant signs
were reported over the entire period, in partic-
ular no weight loss, no cough and no alteration
of his general condition. Inflammation param-
eters were still elevated (CRP 43 mg/L, ESR 40
mm/h, hemoglobin 97 G/L with microcytosis,
leukocyte count 14.5 G/L with 63% neu-
trophils). 
Taking into account the long history of
recurrent daily bouts of fever, the history of
limp and transient skin rash temporally related
to a fever peak, and the ongoing inflammatory
process, a systemic type of juvenile idiopathic
arthritis was suspected and a steroid therapy
started then (600 mg/m2 methylprednisolone
for 3 days by the IV route, then prednisone 2
mg/kg/day orally). However, the fever did not
abate at all and, on the 10th day of therapy, the
steroid drug was stopped and the child was
admitted for investigation in our institution.
Early results suggested a miliary form of tuber-
culosis (mediastinal adenopathies and exten-
sive pulmonary micronodular infiltrate (Figure
2) on the thoraco-abdominal computed tomog-
raphy-scan; enhanced captation of the left
knee capsule (vascular phase) of the distal
part of the left femur and captation of the prox-
imal end of the left tibia and humerus (tissular
and late phase) on the bone scintigraphy; acid-
fast bacilli on a bone marrow sample). An anti-
tuberculous treatment was started with a com-
bination of four antimicrobial drugs (isoni-
azide 5 mg/kg/d, rifampin 10 mg/kg/d, ethamb-
utol 15 mg/kg/d and pyrazinamide 25 mg/kg/d).
Along with the beginning of the treatment, the
child’s condition deteriorated on the 2nd hospi-
tal day as he developed a right-sided hemipare-
sis and showed a decreased level of conscious-
ness. The cerebral imagery showed additional
signs consistent with miliary tuberculosis
(communicating hydrocephalus, multiple
granulomas and multiple ischemic lesions
(Figure 3). The cerebrospinal fluid (CSF) pres-
sure was high (50 mmHg) on lumbar tapping
and the fluid analysis revealed numerous acid-
fast bacilli, an elevated protein (858 mg/L) and
lactate (6.2 mmol/L) content, a low glucose
content (1.2 mmol/L), and a high white blood
cell count (13/mm3, 57% granulocytes). The
Mycobacterium tuberculosis complex PCR per-
formed on the CSF sample was positive (10’000
copies/ml), as well as the CSF culture and the
T-spot TB® test (133 SFU/mio cells) in a later
stage. Eventually, Mycobacterium tuberculosis
was proven to be sensitive (absence of muta-
tions within the rifampin–resistance deter-
mining region of the rpoB gene and satisfacto-
ry response in regular susceptibility tests to all
antimicrobial used). Initially, considering that
the child had no major alteration of conscious-
ness in spite of the cerebral edema, a ventric-
ular derivation device did not seem necessary
and a steroid treatment (4 mg/kg/d) was start-
ed instead. However, on the 3rd hospital day,
the child developed seizures requiring an anti-
convulsive therapy as well as decreased con-
sciousness. Concomitantly, the cerebral
imagery evidenced increased hydrocephalus
and a ventricular derivation device was insert-
ed to drain CSF and monitor the intracranial
pressure. In addition to the above-mentioned
neurological signs, the child presented a left
Horner’s syndrome and an extensive bilateral
chorioretinitis with macular involvement in
the left eye. The external ventricular deriva-
tion device was withdrawn on the 9th hospital
day and the child progressively recovered from
his neurological impairments while on reha-
bilitation therapy. He still showed residual
signs of hemiparesis and a moderate aphasia
at the time of discharge and some degree of
permanent visual impairment was anticipated
in the left eye owing to the persistent macular
lesion.
Discussion
This case raises quite a few of issues, and
leaves some of them unanswered.
First, the risk of tuberculosis was underesti-
mated. Data from the Swiss public health
office indicate that the incidence of new cases
of tuberculosis is around 7/100,000 population
with more than 80% of cases observed in
young migrant adults and the remainder in
elderly Swiss-born individuals reactivating an
ancient infection. Based on these observa-
tions, the common opinion is that children
born into non-migrant families residing in
Switzerland are essentially unconcerned by
the risk of tuberculosis unless exposure is
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clearly identified. In the present case, the
chest X-ray obtained rather early in the fever
period is suggestive of a miliary tuberculosis
but initially not interpreted as such. The mod-
erately elevated ESR was probably not suffi-
ciently taken in account. However, ESR has
been proven to be of little value in diagnosing
tuberculosis; the range of value of ESR is wide
and its elevation has little significant value in
tuberculosis in children.1 Even though the pos-
sibility of tuberculosis is indeed thought of as
a differential diagnosis, it is not seriously con-
sidered given: i) the child’s Swiss household
conditions; ii) the absence of recognized expo-
sure to tuberculosis; iii) and the regional epi-
demiological conditions in fall and winter
characterized by plenty of benign respiratory
viral infections rather than tuberculosis.
Second, this case highlights the difficulties
in identifying the source of tuberculosis trans-
mission. Children are known to be sentinels of
recent adult infection. A pediatric case of
tuberculosis, such as ours, indicates a failure
in the prevention and control of tuberculosis in
the population. Household exposure to a
source case is a frequent and high risk factor
of transmission to children, particularly to
those younger than 2 years of age.2
Consequently, when a pediatric case is identi-
fied, searching for a source case within the
household is of paramount importance in
order to protect other children living in the
same environment. In our country, individuals
at high risk of developing tuberculosis are the
migrant population and comprise adults who
recently arrived from a high endemic area
(regardless of their legal status) and children
born to such adults or in contact with them.
The latter also applies to children having a par-
ent from a high endemic area. Contact with
individuals from these countries is indeed a
risk of tuberculosis transmission, particularly
in children less than 6 years of age.3 In
Switzerland, it is recommended that a detailed
history, a complete physical examination, and
a tuberculosis-screening test (tuberculin skin
test or interferon-α releasing assay in BCG
vaccinated children) be performed in individu-
als belonging to the at-risk population or hav-
ing a history of contact with tuberculosis. In
addition, a chest X-ray is indicated whenever
the person is symptomatic, or has a definite
contact history, or shows a positive tuberculo-
sis-screening test. The search for
Mycobacterium tuberculosis in respiratory
secretions or gastric fluid is recommended on
individuals showing clinical signs compatible
with tuberculosis or an abnormal chest-X ray.
In the present case, health authorities ordered
a contact enquiry aimed at all pediatric and
adult contacts of the sick child (children
attending the same day care center, family
members, acquaintances, day care center per-
sonal). None of the contacts was found to have
an active and contagious tuberculosis disease.
A young adult, undocumented migrant from
South America, announced himself sponta-
neously to health authorities as he was a
neighbor of the family and was coughing for
many months. Active pulmonary tuberculosis
was diagnosed. Another possible source of con-
tamination might be a 4-weeks travel of the
family across Argentina one year earlier.
However, the child's parents have no recollec-
tion of dealing with someone they would sus-
pect of having tuberculosis. Molecular typing
of both isolates seemed to be different.4,5 In
conclusion, we have at this stage no idea of
where, when and how this child got infected
while living in a low endemic area and seem-
ingly away from at-risk populations.
Third, control of tuberculosis is a challenge
in undocumented migrants. In the present
case, the concerned undocumented migrant
can be exonerated from being the source case
of tuberculosis since his isolate of
Mycobacterium tuberculosis and that of the
Case Report
Figure 1. Full-face chest X-ray: bilateral micronodular parenchymal lesions. Profile: dif-
fuse micronodular opacity including anterior mediastinum.
Figure 2. Thoracic computed tomography-
scan: diffuse bilateral micronodular infil-
trate; one nodular lesion (diameter: 1 cm). 
Figure 3. Left Panel) multiple contrast-enhanced nodular lesions of the whole encephalus
on T1 sequence cerebral magnetic resonance imaging (MRI). Central Panel) Cerebral
computed tomography-scan demonstrating enhancing hydrocephalus and hypodense
lesion of left thalamic region two days later. Right Panel) Evolution after 7 weeks of anti-
tuberculous and steroids therapy: disappearance of nodular lesions, persistence of hydro-
cephalus and thalamic ischemic lesion on T1-weighted + gadolinium MRI. 
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child are genetically different. However, tuber-
culosis control is obviously quite a challenge in
this population. First of all, because of their
illegal status, undocumented migrants escape
the tuberculosis screening set up for legal
migrants. Then, for socioeconomic reasons,
they tend to have a restricted access to medical
care because of lack of health insurance cover-
age. In Switzerland, illegal migrants represent
a significant proportion of the resident popula-
tion (1-2% of the total population) and most of
them come from high endemic countries. They
represent a potential source of uncontrolled
disease transmission and efforts must be con-
tinued to adequately control tuberculosis in
such a vulnerable population.6
Forth, steroid therapy was inappropriate.
This child was given a steroid therapy for a pre-
sumed juvenile idiopathic arthritis while devel-
oping a tuberculosis disease. As immunosup-
pressive drugs are known to be risk factors for
tuberculosis disease extension,2 the steroid
therapy is very likely to have accelerated and/or
amplified the process. However, it might be
argued that the rapid clinical deterioration sec-
ondary to prednisone therapy prompted diag-
nostic procedures within a short time frame
allowing identification of the disease and the
starting of an adequate antimicrobial treat-
ment possibly earlier than if the natural course
was sole at play. It can be argued whether the
inadvertent steroid drug had a downmodulating
effect on the growing cerebral edema accompa-
nying the miliary infection in the brain. The
close temporal relation is striking between the
cessation of the prednisone therapy and the
onset of clinical manifestations of increased
intracranial pressure.
Fifth, the delay in diagnosis leads to serious
neurological consequences. Tuberculosis is
associated with serious acute manifestations
and long-term sequelae in case of central nerv-
ous system involvement. In addition, according
to US and British guidelines, a cerebral
involvement implies a much longer duration of
antimicrobial therapy. Mortality rate of tuber-
culous meningitis is high (20-50%); poor out-
come predictors are young age, stage of dis-
ease at presentation and specific pattern of
distribution of ischemic lesions.7 Hydroce -
phalus is a common complication (70%) and 4
out of 5 cases present with a communicating
type.8 Medical and/or surgical treatments are
well recognized to improve the clinical out-
come but the most effective therapy of hydro-
cephalus is not determined yet. There are
reports that early surgery should be reserved
for those with obstructive hydrocephalus
whereas medical therapy should be tried ini-
tially in those with a communicating form of
hydrocephalus.9 However, a ventricular deriva-
tion device should be inserted promptly in the
face of decreasing consciousness or increas-
ing hydrocephalus on imagery. According to
the latest Cochrane review, mortality and long
term sequelae are decreased in HIV negative
children when steroid therapy is used.10 In the
present case, cerebral lesions had almost dis-
appeared after 7 weeks of anti-tuberculous and
steroids treatment (Figure 3). After 6 months
of evolution, the child recovered most of his
hemiparesis but still had features of behav-
ioral disturbances and aggressiveness, which
may be attributed to cerebral lesions. Close
neurological follow-up is needed to determine
cognitive and neurological development.
Pulmonary tuberculosis is quite rare in the
Swiss-born pediatric population and miliary
tuberculosis even more so. The present case is
indeed the only one recorded over recent
decades in our institution. However, it is proof
that tuberculosis can be transmitted to Swiss-
born children without known contact with an
at-risk population. That reminds us that the
suspicion of tuberculosis must not be rejected
without further ado in a Swiss-born child on
ground that Switzerland is a low incidence
country. Tuberculosis should be systematically
considered in children with fever of unknown
origin and screening performed with a tuber-
culin skin test or an interferon-α-releasing
assay. Tuberculosis should also be systemati-
cally screened for in all children about to start
an immunosuppressive therapy since immune
suppression and young age are well recognized
risk factors for the rapid development of dis-
ease in children with a latent tuberculosis
infection,2 particularly so among children less
than 2-3 years old.
Conclusions
Tuberculosis remains a major public health
problem worldwide, and HIV infection or multi-
ple drug resistant tuberculosis present major
challenges for the control of this disease.11,12
Paradoxically, in low incidence areas such as
Switzerland, the risk of childhood tuberculosis
tends to be overlooked with delays in diagnosis
and adequate therapy. This case report
reminds us how important it is to consider
tuberculosis whenever facing a young child
with fever and unspecific signs or symptoms.
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